Technology | June 07, 2010

Nuclear Scanner Failures Detected With Real-Time Monitoring


June 7, 2010 – A program proactively monitors molecular imaging system performance online and in real-time to help predict scanner breakdowns. The system can also detect the majority of potential computed tomography (CT) tube failures.

Siemens Healthcare today launched the Guardian Program to monitor critical parameters. The TubeGuard software for the Biograph mCT, an option of the Guardian Program, helps predict the CT tube failures.

Whether detecting cancer, or conducting heart or brain imaging, renal exams or bone scans, physicians must be able to rely on their PET-CT or nuclear medicine scanners. Any system downtime can have significant costs to customers, since an expensive radiopharmaceutical dose must be ordered specifically for each patient in advance of the examination. In order to help assure the highest availability of the scanners, Siemens has extended its Guardian Program to enable proactive online monitoring in real-time for the Biograph mCT, Biograph TruePoint, Symbia S and Symbia T product lines.

If parameters exceed or undershoot defined critical levels, the system will proactively send a message to the Siemens Service Center. This will trigger a predefined, high-speed support and repair process with clearly defined reaction and repair times. A service expert will guide the customer through the first critical phase and help re-establish the system’s availability as fast as possible.

TubeGuard can now predict the majority of all potential CT tube failures within Biograph mCT. More than 10 sensors monitor the tube functions with Siemens Remote Service (SRS). Tube exchanges can be scheduled in advance and unplanned downtime can be avoided.

For more information: www.siemens.com/healthcare


Related Content

News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 18, 2024
Home
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 14, 2024
Home
News | PET Imaging

October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

Home October 05, 2023
Home
News | PET Imaging

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

Home December 01, 2022
Home
News | PET Imaging

September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...

Home September 14, 2022
Home
News | PET Imaging

August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...

Home August 25, 2022
Home
News | PET Imaging

June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Home June 15, 2022
Home
Technology | PET Imaging

December 5, 2018 — Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ...

Home December 05, 2018
Home
News | PET Imaging

July 17, 2018 — A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new ...

Home July 17, 2018
Home
News | PET Imaging

July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are ...

Home July 07, 2017
Home
Subscribe Now